Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by type

1.4.2. Market size breakdown, by application

1.4.3. Market size breakdown, by animal

1.4.4. Market size breakdown, by end user

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics

5.1.1. Trends

5.1.2. Drivers

5.1.3. Restraints/challenges

5.1.4. Impact analysis of drivers/restraints

5.2. Impact of COVID-19

5.3. Porter’s Five Forces Analysis

5.3.1. Bargaining power of buyers

5.3.2. Bargaining power of suppliers

5.3.3. Threat of new entrants

5.3.4. Intensity of rivalry

5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview

6.2. Market Revenue, by Type (2017–2030)

6.3. Market Revenue, by Application (2017–2030)

6.3.1. Surgery market revenue, by type (2017–2030)

6.4. Market Revenue, by Animal (2017–2030)

6.5. Market Revenue, by End User (2017–2030)

6.6. Market Revenue, by Region (2017–2030)

Chapter 7. North America Market

7.1. Overview

7.2. Market Revenue, by Type (2017–2030)

7.3. Market Revenue, by Application (2017–2030)

7.3.1. Surgery market revenue, by type (2017–2030)

7.4. Market Revenue, by Animal (2017–2030)

7.5. Market Revenue, by End User (2017–2030)

7.6. Market Revenue, by Country (2017–2030)

Chapter 8. Europe Market

8.1. Overview

8.2. Market Revenue, by Type (2017–2030)

8.3. Market Revenue, by Application (2017–2030)

8.3.1. Surgery market revenue, by type (2017–2030)

8.4. Market Revenue, by Animal (2017–2030)

8.5. Market Revenue, by End User (2017–2030)

8.6. Market Revenue, by Country (2017–2030)

Chapter 9. APAC Market

9.1. Overview

9.2. Market Revenue, by Type (2017–2030)

9.3. Market Revenue, by Application (2017–2030)

9.3.1. Surgery market revenue, by type (2017–2030)

9.4. Market Revenue, by Animal (2017–2030)

9.5. Market Revenue, by End User (2017–2030)

9.6. Market Revenue, by Country (2017–2030)

Chapter 10. LATAM Market

10.1. Overview

10.2. Market Revenue, by Type (2017–2030)

10.3. Market Revenue, by Application (2017–2030)

10.3.1. Surgery market revenue, by type (2017–2030)

10.4. Market Revenue, by Animal (2017–2030)

10.5. Market Revenue, by End User (2017–2030)

10.6. Market Revenue, by Country (2017–2030)

Chapter 11. MEA Market

11.1. Overview

11.2. Market Revenue, by Type (2017–2030)

11.3. Market Revenue, by Application (2017–2030)

11.3.1. Surgery market revenue, by type (2017–2030)

11.4. Market Revenue, by Animal (2017–2030)

11.5. Market Revenue, by End User (2017–2030)

11.6. Market Revenue, by Country (2017–2030)

Chapter 12. U.S. Market

12.1. Overview

12.2. Market Revenue, by Type (2017–2030)

12.3. Market Revenue, by Application (2017–2030)

12.3.1. Surgery market revenue, by type (2017–2030)

12.4. Market Revenue, by Animal (2017–2030)

12.5. Market Revenue, by End User (2017–2030)

Chapter 13. Canada Market

13.1. Overview

13.2. Market Revenue, by Type (2017–2030)

13.3. Market Revenue, by Application (2017–2030)

13.3.1. Surgery market revenue, by type (2017–2030)

13.4. Market Revenue, by Animal (2017–2030)

13.5. Market Revenue, by End User (2017–2030)

Chapter 14. Germany Market

14.1. Overview

14.2. Market Revenue, by Type (2017–2030)

14.3. Market Revenue, by Application (2017–2030)

14.3.1. Surgery market revenue, by type (2017–2030)

14.4. Market Revenue, by Animal (2017–2030)

14.5. Market Revenue, by End User (2017–2030)

Chapter 15. France Market

15.1. Overview

15.2. Market Revenue, by Type (2017–2030)

15.3. Market Revenue, by Application (2017–2030)

15.3.1. Surgery market revenue, by type (2017–2030)

15.4. Market Revenue, by Animal (2017–2030)

15.5. Market Revenue, by End User (2017–2030)

Chapter 16. U.K. Market

16.1. Overview

16.2. Market Revenue, by Type (2017–2030)

16.3. Market Revenue, by Application (2017–2030)

16.3.1. Surgery market revenue, by type (2017–2030)

16.4. Market Revenue, by Animal (2017–2030)

16.5. Market Revenue, by End User (2017–2030)

Chapter 17. Italy Market

17.1. Overview

17.2. Market Revenue, by Type (2017–2030)

17.3. Market Revenue, by Application (2017–2030)

17.3.1. Surgery market revenue, by type (2017–2030)

17.4. Market Revenue, by Animal (2017–2030)

17.5. Market Revenue, by End User (2017–2030)

Chapter 18. Spain Market

18.1. Overview

18.2. Market Revenue, by Type (2017–2030)

18.3. Market Revenue, by Application (2017–2030)

18.3.1. Surgery market revenue, by type (2017–2030)

18.4. Market Revenue, by Animal (2017–2030)

18.5. Market Revenue, by End User (2017–2030)

Chapter 19. Japan Market

19.1. Overview

19.2. Market Revenue, by Type (2017–2030)

19.3. Market Revenue, by Application (2017–2030)

19.3.1. Surgery market revenue, by type (2017–2030)

19.4. Market Revenue, by Animal (2017–2030)

19.5. Market Revenue, by End User (2017–2030)

Chapter 20. China Market

20.1. Overview

20.2. Market Revenue, by Type (2017–2030)

20.3. Market Revenue, by Application (2017–2030)

20.3.1. Surgery market revenue, by type (2017–2030)

20.4. Market Revenue, by Animal (2017–2030)

20.5. Market Revenue, by End User (2017–2030)

Chapter 21. India Market

21.1. Overview

21.2. Market Revenue, by Type (2017–2030)

21.3. Market Revenue, by Application (2017–2030)

21.3.1. Surgery market revenue, by type (2017–2030)

21.4. Market Revenue, by Animal (2017–2030)

21.5. Market Revenue, by End User (2017–2030)

Chapter 22. Australia Market

22.1. Overview

22.2. Market Revenue, by Type (2017–2030)

22.3. Market Revenue, by Application (2017–2030)

22.3.1. Surgery market revenue, by type (2017–2030)

22.4. Market Revenue, by Animal (2017–2030)

22.5. Market Revenue, by End User (2017–2030)

Chapter 23. South Korea Market

23.1. Overview

23.2. Market Revenue, by Type (2017–2030)

23.3. Market Revenue, by Application (2017–2030)

23.3.1. Surgery market revenue, by type (2017–2030)

23.4. Market Revenue, by Animal (2017–2030)

23.5. Market Revenue, by End User (2017–2030)

Chapter 24. Brazil Market

24.1. Overview

24.2. Market Revenue, by Type (2017–2030)

24.3. Market Revenue, by Application (2017–2030)

24.3.1. Surgery market revenue, by type (2017–2030)

24.4. Market Revenue, by Animal (2017–2030)

24.5. Market Revenue, by End User (2017–2030)

Chapter 25. Mexico Market

25.1. Overview

25.2. Market Revenue, by Type (2017–2030)

25.3. Market Revenue, by Application (2017–2030)

25.3.1. Surgery market revenue, by type (2017–2030)

25.4. Market Revenue, by Animal (2017–2030)

25.5. Market Revenue, by End User (2017–2030)

Chapter 26. Saudi Arabia Market

26.1. Overview

26.2. Market Revenue, by Type (2017–2030)

26.3. Market Revenue, by Application (2017–2030)

26.3.1. Surgery market revenue, by type (2017–2030)

26.4. Market Revenue, by Animal (2017–2030)

26.5. Market Revenue, by End User (2017–2030)

Chapter 27. South Africa Market

27.1. Overview

27.2. Market Revenue, by Type (2017–2030)

27.3. Market Revenue, by Application (2017–2030)

27.3.1. Surgery market revenue, by type (2017–2030)

27.4. Market Revenue, by Animal (2017–2030)

27.5. Market Revenue, by End User (2017–2030)

Chapter 28. U.A.E. Market

28.1. Overview

28.2. Market Revenue, by Type (2017–2030)

28.3. Market Revenue, by Application (2017–2030)

28.3.1. Surgery market revenue, by type (2017–2030)

28.4. Market Revenue, by Animal (2017–2030)

28.5. Market Revenue, by End User (2017–2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings

29.2. Competitive Benchmarking of Key Players

29.3. Product Benchmarking of Key Players

29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. Charles River Laboratories International Inc.

30.1.1. Business overview

30.1.2. Product and service offerings

30.1.3. Key financial summary

30.2. Merck KGaA

30.2.1. Business overview

30.2.2. Product and service offerings

30.2.3. Key financial summary

30.3. Thermo Fisher Scientific Inc.

30.3.1. Business overview

30.3.2. Product and service offerings

30.3.3. Key financial summary

30.4. FUJIFILM Wako Pure Chemical Corporation

30.4.1. Business overview

30.4.2. Product and service offerings

30.4.3. Key financial summary

30.5. WuXi AppTec Co. Ltd.

30.5.1. Business overview

30.5.2. Product and service offerings

30.5.3. Key financial summary

30.6. Microcoat Biotechnologie GmbH

30.6.1. Business overview

30.6.2. Product and service offerings

30.6.3. Key financial summary

30.7. Nelson Laboratories LLC

30.7.1. Business overview

30.7.2. Product and service offerings

30.7.3. Key financial summary

30.8. Lonza Group Ltd.

30.8.1. Business overview

30.8.2. Product and service offerings

30.8.3. Key financial summary

30.9. Ellab A/S

30.9.1. Business overview

30.9.2. Product and service offerings

30.9.3. Key financial summary

30.10. GenScript Biotech Corporation

30.10.1. Business overview

30.10.2. Product and service offerings

30.10.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations

31.2. Sources and References

31.3. Related Reports

※参考情報 パイロジェン検査とは、医薬品や医療機器が体内に入ったときに発熱を引き起こす可能性のある物質、すなわちパイロジェンの存在を確認するための試験です。パイロジェンは主に細菌やその代謝物、またはウイルスなどが原因であり、特に内因性のエンドトキシンは、グラム陰性菌の細胞壁に存在する成分で、強い発熱反応を引き起こします。このため、多くの医薬品の製造過程や医療機器の滅菌プロセスにおいて、パイロジェン検査は欠かせない工程となっています。 パイロジェン検査には主に二つの種類があります。一つは、ラッサルト試験です。この試験は、ウサギの血液を使用してパイロジェンの影響を確認します。ウサギに試験対象物質を投与し、その後体温の変化を測定します。体温が上昇した場合、その物質にはパイロジェンが含まれている可能性があります。もう一つは、LAL試験（リムルスアメボサイトリシス試験）です。この試験は、海の生物であるイカやヤドカリの血液成分を使用します。LAL試験は、エンドトキシンに特異的に反応するため、高い感度と特異性を持ち、迅速に結果が得られることから広く利用されています。 パイロジェン検査の主な用途は、医薬品や医療機器の安全性を確保することです。例えば、注射剤や点滴液など、直接体内に進入する製品においては、パイロジェンの除去が必須です。これにより、製品が体に与える影響を最小限に抑えることが可能となります。また、パイロジェンの有無は、製品の品質や製造プロセスのバリデーションにも重要な要素です。製品の開発段階では、パイロジェン検査を実施することで、製造工程の改善点を特定し、最終的な製品の品質向上につなげることができます。 最近では、パイロジェン検査に関連する技術も進化しています。例えば、分子生物学的技術を用いた検出方法が注目されています。これにより、従来の検査方法に比べて、より高感度かつ迅速なパイロジェン検査が可能になると期待されています。また、バイオセンサーを活用した新しい技術も研究されており、迅速かつ自動化されたパイロジェン検査が実現できる可能性があります。これにより、製薬業界だけでなく、食品業界や化粧品業界においても、パイロジェン検査の重要性が一層高まるでしょう。 さらに、国際的な規制や標準に基づいた検査法も重要です。たとえば、アメリカ食品医薬品局（FDA）や国際会議における規格であるISOに基づくガイドラインは、パイロジェン検査の実施における基準を提供しています。これにより、医薬品や医療機器が世界各国で受け入れられるための信頼性を確保することができます。 以上のように、パイロジェン検査は医薬品や医療機器の安全性を評価する上で非常に重要な役割を果たしています。その技術の進歩や新しい検査方法の開発は、今後さらに期待されている分野です。特に、製造プロセスの自動化や迅速化を実現することで、医療の質を向上させることが可能となります。これにより、患者さんに対する安全性の確保だけでなく、業界全体の効率化にも寄与することができます。これからの時代においても、パイロジェン検査は医療の発展に欠かせない要素であり続けるでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer